Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants

被引：0

作者：

Draelos, Zoe ^{[1
]}

Tanghetti, Emil ^{[2
]}

Gold, Linda Stein ^{[3
]}

Kircik, Leon ^{[4
]}

Bhatia, Neal ^{[5
]}

Zeichner, Joshua ^{[4
]}

Sugarman, Jeffrey ^{[6
]}

机构：

[1] Dermatol Consulting Serv PLLC, High Point, NC USA

[2] Ctr Dermatol & Laser Surg, High Point, NC USA

[3] Henry Ford Hosp, Detroit, MI USA

[4] Icahn Sch Med Mt Sinai, New York, NY USA

[5] Therapeut Clin Res, New York, NY USA

[6] Univ Calif San Francisco, San Francisco, CA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

43390

引用

页码：AB33 / AB33

页数：1

共 50 条

[21] Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy
Loesche, Christian
Pernin, Colette
Poncet, Michel
EUROPEAN JOURNAL OF DERMATOLOGY, 2008, 18 (05) : 524 - 526
[22] A pivotal study comparing the efficacy and safety of the adapalene-benzoyl peroxide fixed-dose combination gel with each component and the vehicle in 1668 patients with acne vulgaris
Gold, Linda Stein
Tan, Jerry
Papp, Kim
Poulin, Yves
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB16 - AB16
[23] Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in the treatment of severe acne
Webster, Guy
Gold, Michael
Rich, Phoebe
Mraz, Serena
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB17 - AB17
[24] Efficacy of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate to severe acne Diane
Thiboutot, Diane
Shalita, Alan
Zaenglein, Andrea
Calvarese, Barry
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB22 - AB22
[25] Moderate to Severe Acne in Adolescents With Skin of Color: Benefits of a Fixed Combination Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Aqueous Gel
Eichenfield, Lawrence F.
Krakowski, Andrew C.
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (07) : 818 - 824
[26] Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations
Gold, Linda Stein
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (09) : 969 - 974
[27] Gender as a Clinically Relevant Outcome Variable in Acne: Benefits of a Fixed Combination Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (2.5%) Aqueous Gel
Harper, Julie C.
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (12) : 1440 - 1445
[28] Safety and Efficacy of Clindamycin Phosphate 1.2% Benzoyl Peroxide 3% Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Phase 3, Multicenter, Randomized, Double-Blind, Active- and Vehicle-Controlled Study
Eichenfield, Lawrence F.
Saenz, Alessandra B. Alio
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (12) : 1382 - 1396
[29] Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed dose combination gel for the treatment of acne vulgaris: A multicenter, double-blind, parallel group, vehicle controlled study
Eichenfield, Lawrence
Alio, Alessandra
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB10 - AB10
[30] Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Low Concentration Benzoyl Peroxide (2.5%) Aqueous Gel in Moderate or Severe Acne Subpopulations
Webster, Guy
Rich, Phoebe
Gold, Michael H.
Mraz, Serena
Calvarese, Barry
Chen, Diana
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 736 - 743

← 1 2 3 4 5 →